Tag

#Lung Cancer

Home » Lung Cancer

35 posts
Bookmark?Remove?

Strides in lung cancer lead steep decline in U.S. death rates

(Reuters Health) – Cancer death rates in the United States fell 2.2% from 2016 to 2017 – the largest single-year drop ever recorded – fueled in large part by progress against lung cancer, the leading cause of cancer death, the American Cancer Society (ACS) rep... More »

Bookmark?Remove?

Cancer doctors don’t focus on lifestyle risks

(Reuters Health) – Cancer specialists only rarely advise patients on lifestyle changes that could improve overall health and possibly also reduce the risk of recurrence, a new survey suggests. The survey of doctors from a Midwestern health system found that on... More »

Bookmark?Remove?

WHO hails progress in fight against tobacco but wants more

LONDON (Reuters) – Healthy progress has been made in reducing smoking and tobacco use, but governments need to do more to help the world’s 1.1 billion smokers quit, the World Health Organization said on Friday. Tobacco use has also declined proportionately in ... More »

Bookmark?Remove?

Hospitals serving more minorities may offer less palliative care

(Reuters Health) – Patients may have less access to palliative care at U.S. hospitals that primarily serve minorities, a study suggests. Minorities in the U.S. often receive worse healthcare and have worse outcomes, researchers note in JAMA Network Open. Non-w... More »

Bookmark?Remove?

Merck’s Keytruda extends lung cancer survival in two trials

CHICAGO (Reuters) – Merck & Co’s immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for hard-to-treat squamous cell lung cancer, new data released on Sunday showed, further cementi... More »

Bookmark?Remove?

Grail blood test shows promise in early detection of lung cancer

CHICAGO (Reuters) – An experimental blood screening test from Grail Inc showed early promise in detecting early-stage lung cancers based on free-floating DNA released by tumors, according to preliminary results released on Saturday. The findings, presented at ... More »

Bookmark?Remove?

As cancer drug prices climb, value not keeping pace

(Reuters Health) – The cost of new anti-cancer drugs increased more than five-fold from 2006 to 2015, but a new analysis suggests that cancer patients and insurers may be getting less for their money. Anticancer medications account for the lion’s share of glob... More »

Bookmark?Remove?

Few Americans aware of cancer drug shortages

(Reuters Health) – Most Americans aren’t aware of cancer drug shortages that might lead some patients to receive less effective or more toxic treatments, a U.S. study suggests. In a nationally representative survey of 420 adults, just 16 percent said they knew... More »

Bookmark?Remove?

AstraZeneca’s immunotherapy drug wins key lung cancer approval

FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo LONDON (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, ope... More »

Bookmark?Remove?

U.S. panel deals blow to Philip Morris tobacco device

FILE PHOTO: A man poses for a photograph while using a Philip Morris iQOS smoking device, in Bogota, Colombia November 14, 2017. REUTERS/Jaime Saldarriaga/File Photo WASHINGTON (Reuters) – Philip Morris International Inc should not be allowed to claim its iQOS... More »

Bookmark?Remove?

Roche drug cocktail doubles chance of holding lung cancer at bay

FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland, January 30, 2014. REUTERS/Ruben Sprich/File Photo ZURICH (Reuters) – Adding Roche’s (ROG.S) immunotherapy Tecentriq to older drugs doubled the ... More »

Bookmark?Remove?

U.S. FDA approves Merck immunotherapy/chemo combo for lung cancer

A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck’s pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky Merck & ... More »

Bookmark?Remove?

AbbVie cancer drug fails two late-stage trials

A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. Shire said on July 18 that it had accepted an offer of 32 billion pounds ($54.7 billion) from AbbVie. REUTERS/Brendan McDermid AbbVie I... More »

Bookmark?Remove?

Tobacco treaty has helped cut smoking rates, but more work needed

A customer smokes a cigarette in a cafe in Prague, Czech Republic, May 25, 2016. REUTERS/David W Cerny/File Photo A global tobacco treaty put in place in 2005 has helped reduce smoking rates by 2.5 percent worldwide in 10 years, researchers said on Tuesday, bu... More »

U.S. spends $3 billion a year on unused cancer drugs

(Reuters Health) – U.S. doctors and hospitals throw out almost $3 billion (roughly 2.7 billion euros) in unused cancer drugs each year because the medicines come in supersized single-use packages and excess medicine must be discarded for safety reasons, a rece... More »

FDA expands approval of Merck’s Keytruda to lung cancer

The U.S. Food and Drug Administration on Friday approved Merck & Co Inc’s immunotherapy, Keytruda, for patients with the most common form of lung cancer whose tumors produce a specific biological marker. The FDA approval for Keytruda in advanced non-small cell... More »

WHO urges governments to raise tobacco taxes to beat smoking

LONDON Governments around the world should increase taxes on cigarettes and other tobacco products to save lives and generate funds for stronger health services, the World Health Organization (WHO) said on Tuesday. In a report entitled “The Global Tobacco Epid... More »